Management targets continued 2026 growth despite Medicare Advantage, regulatory, and facility-closure headwinds [31][42][142].
| Quarter | Q4 FY25 |
|---|---|
| Call date | 2026-02-07 |
| Length | 66 minutes |
| EPS | $1.46 |
| EPS consensus | $1.29 |
| Revenue | $1.5B |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q2 FY25 · Q1 FY25
All EHC earnings · Back to EHC overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.